These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22288409)

  • 1. Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases.
    Niitsu T; Iyo M; Hashimoto K
    Curr Pharm Des; 2012; 18(7):875-83. PubMed ID: 22288409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders.
    Albayrak Y; Hashimoto K
    Adv Exp Med Biol; 2017; 964():153-161. PubMed ID: 28315270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication.
    Hashimoto K
    J Pharmacol Sci; 2015 Jan; 127(1):6-9. PubMed ID: 25704012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
    Hashimoto K; Fujita Y; Iyo M
    Neuropsychopharmacology; 2007 Mar; 32(3):514-21. PubMed ID: 16495935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship.
    Hashimoto K
    Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):197-204. PubMed ID: 20021354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
    Nishimura T; Ishima T; Iyo M; Hashimoto K
    PLoS One; 2008 Jul; 3(7):e2558. PubMed ID: 18596927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
    Ishima T; Fujita Y; Hashimoto K
    Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?
    Hashimoto K
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):470-4. PubMed ID: 19702566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.
    Kunitachi S; Fujita Y; Ishima T; Kohno M; Horio M; Tanibuchi Y; Shirayama Y; Iyo M; Hashimoto K
    Brain Res; 2009 Jul; 1279():189-96. PubMed ID: 19433073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.
    Hayashi T; Su TP
    CNS Drugs; 2004; 18(5):269-84. PubMed ID: 15089113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor.
    Matsushima Y; Terada K; Kamei C; Sugimoto Y
    Eur J Pharmacol; 2019 Jun; 853():129-135. PubMed ID: 30902656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.
    Ishikawa M; Ishiwata K; Ishii K; Kimura Y; Sakata M; Naganawa M; Oda K; Miyatake R; Fujisaki M; Shimizu E; Shirayama Y; Iyo M; Hashimoto K
    Biol Psychiatry; 2007 Oct; 62(8):878-83. PubMed ID: 17662961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered.
    Hindmarch I; Hashimoto K
    Hum Psychopharmacol; 2010 Apr; 25(3):193-200. PubMed ID: 20373470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of sigma-1 receptors in neural plasticity and in antipsychotic action].
    Hashimoto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):123-7. PubMed ID: 20666143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats.
    Senda T; Matsuno K; Okamoto K; Kobayashi T; Nakata K; Mita S
    Eur J Pharmacol; 1996 Nov; 315(1):1-10. PubMed ID: 8960858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors.
    Takebayashi M; Hayashi T; Su TP
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S208-13. PubMed ID: 15547787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells.
    Matsushima Y; Terada K; Takata J; Karube Y; Kamei C; Sugimoto Y
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):659-665. PubMed ID: 30543144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors.
    Zvejniece L; Vavers E; Svalbe B; Vilskersts R; Domracheva I; Vorona M; Veinberg G; Misane I; Stonans I; Kalvinsh I; Dambrova M
    Br J Pharmacol; 2014 Feb; 171(3):761-71. PubMed ID: 24490863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral pharmacology of sigma-ligands.
    Skuza G; Wedzony K
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S183-8. PubMed ID: 15547784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia.
    Iyo M; Shirayama Y; Watanabe H; Fujisaki M; Miyatake R; Fukami G; Shiina A; Nakazato M; Shiraishi T; Ookami T; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1072-3. PubMed ID: 18262707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.